Search
Search Results
##search.searchResults.foundPlural##
-
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1816PDF: 714HTML: 2101Untitled: 211Untitled: 151Untitled: 167Untitled: 152Untitled: 160Untitled: 175Untitled: 183 -
Evaluating the use of meropenem in hematologic patients with febrile neutropenia A retrospective observational single-cohort study
969PDF: 443HTML: 132 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4465PDF: 1914HTML: 17733 -
WHAT ARE FUNGAL INFECTIONS?
4160PDF: 2367HTML: 27593de Pauw: 235 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
944PDF: 1204HTML: 106 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3302PDF: 1463HTML: 3996 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3666PDF: 1433HTML: 181 -
Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis
1556PDF: 769HTML: 1299 -
-
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2802PDF: 944HTML: 7330 -
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1095PDF: 485HTML: 8162 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2769PDF: 1011HTML: 360Preferred Reviewers: 204 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2086PDF: 985HTML: 4067Cover Letter: 219Figure 1: 229Figure 2: 228Table 1: 202 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2209PDF: 961HTML: 1890 -
Major Artery Occlusion: a Rare Complication of Sickle Cell Disease
1352PDF: 1031HTML: 4601 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1015PDF: 609HTML: 73 -
CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2503PDF: 942HTML: 2228 -
AN INEXPENSIVE CLINICAL-LABORATORY NOMOGRAM TO PREDICT POST-TREATMENT LUNG DESTRUCTION IN PULMONARY TUBERCULOSIS
549PDF: 257Suppl. Files: 69Html: 42 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3364PDF: 1288HTML: 1861Fig.1: 198Fig. 2: 204 -
PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.
2477PDF: 1154HTML: 11795 -
EPIDEMIOLOGY OF IMPORTED MALARIA IN THE MEDITERRANEAN REGION
3106PDF: 1039HTML: 16412 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2572PDF: 797HTML: 5207 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
716PDF: 463HTML: 6264 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2156PDF: 1577HTML: 262 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1228PDF: 976HTML: 209 -
THE IMPACT OF HUMAN PLATELET ANTIGEN ALLELE ON ANTIPLATELET ANTIBODIES AND CRYOGLOBULINS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA AND HEPATITIS C VIRUS-ASSOCIATED IMMUNE THROMBOCYTOPENIA Human platelet antigen and immune thrombocytopenia
1001PDF: 855Suppl. Files: 455HTML: 284 -
SERO PREVALENCE OF TOXARA CANIS IN THE CITY OF CATANIA, ITALY.
1358PDF: 939HTML: 219 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3361PDF: 1277HTML: 2212Fi.1 Gritti.Rambaldi: 203 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12329PDF: 1672HTML: 4164Cover letter: 196Figure 1: 202 -
AGE AT DIAGNOSIS OF SICKLE CELL ANAEMIA IN LAGOS, NIGERIA
1969PDF: 895HTML: 1861







